Literature DB >> 28095016

Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.

Carlos Nicolau1,2, Evis Sala1, Anita Kumar3, Debra A Goldman4, Heiko Schoder1, Hedvig Hricak1, Hebert Alberto Vargas1.   

Abstract

OBJECTIVE: The purpose of this study is to analyze the 18F-FDG PET/CT features of solid renal masses detected in patients with lymphoma and to evaluate the ability of PET/CT to differentiate renal cell carcinoma (RCC) from renal lymphomatous involvement.
MATERIALS AND METHODS: Thirty-six patients with solid renal masses on PET/CT performed for staging or follow-up of lymphoma were evaluated retrospectively. The features recorded for each renal mass included the following standardized uptake values (SUVs) on PET/CT: the maximum SUV (SUVmax), the mean SUV (SUVmean), the ratio of the SUVmax of the tumor to that of the normal kidney cortex, the ratio of the SUVmean of the tumor to that of the normal kidney cortex, the ratio of the SUVmax of the tumor to that of the normal liver, and the ratio of the SUVmean of the tumor to that of the normal liver. Renal mass size and margins (well defined vs infiltrative) and the presence of calcifications were evaluated on CT. Renal biopsy results were used as the reference standard. Relationships between imaging parameters and histopathologic findings were assessed.
RESULTS: Of the 36 renal masses evaluated, 22 (61.1%) were RCCs and 14 (38.9%) were renal lymphomas. All SUV metrics were higher for renal lymphomas than for RCCs (p < 0.0001, for all). All renal lymphomas had an SUVmax higher than 5.98 g/mL (median, 10.99 g/mL), whereas all RCCs had an SUVmax lower than 5.26 g/mL (median, 2.91 g/mL). No statistically significant differences in mass size or margins were found between RCCs and renal lymphoma.
CONCLUSION: PET/CT features may be useful for differentiating RCCs from renal involvement in patients with lymphoma with solid renal masses.

Entities:  

Keywords:  CT; PET; cancer; lymphoma; renal cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28095016      PMCID: PMC5548005          DOI: 10.2214/AJR.16.17133

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  25 in total

1.  18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.

Authors:  Xiang-Hua Ye; Long-Hua Chen; Hu-Bing Wu; Jie Feng; Wen-Lan Zhou; Rui-Meng Yang; Zhi-Bin Bu; Yi Ding; Jian Guan; Quan-Shi Wang
Journal:  South Med J       Date:  2010-07       Impact factor: 0.954

Review 2.  FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature.

Authors:  Tomohiro Kaneta; Takashi Hakamatsuka; Takayuki Yamada; Kei Takase; Akihiro Sato; Shuichi Higano; Shigeo Kinomura; Hiroshi Fukuda; Shoki Takahashi; Shogo Yamada
Journal:  Ann Nucl Med       Date:  2006-01       Impact factor: 2.668

Review 3.  PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.

Authors:  Katherine Zukotynski; Aaron Lewis; Kevin O'Regan; Heather Jacene; Christopher Sakellis; Samuel Almodovar; David Israel
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

4.  Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?

Authors:  Georgia Keramida; Sabina Dizdarevic; Janice Bush; A Michael Peters
Journal:  Eur Radiol       Date:  2015-04-22       Impact factor: 5.315

Review 5.  The role of contrast agents in the diagnosis of renal diseases.

Authors:  Carlos Nicolau; Iban Aldecoa; Laura Bunesch; Carme Mallofre; Carmen Sebastia
Journal:  Curr Probl Diagn Radiol       Date:  2015-02-10

6.  Assessment of the diagnostic performance of (18)F-FDG-PET/CT for detection and characterization of solid renal malignancies.

Authors:  Zein Nakhoda; Drew A Torigian; Babak Saboury; Frank Hofheinz; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2013-03-26       Impact factor: 1.102

Review 7.  Management of the incidental renal mass.

Authors:  Stuart G Silverman; Gary M Israel; Brian R Herts; Jerome P Richie
Journal:  Radiology       Date:  2008-10       Impact factor: 11.105

8.  Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.

Authors:  Anuradha Kunthur; Peter H Wiernik; Janice P Dutcher
Journal:  Am J Hematol       Date:  2006-04       Impact factor: 10.047

9.  Renal involvement in lymphoma: prevalence and various patterns of involvement on abdominal CT.

Authors:  Mohammed Sherif El-Sharkawy; Neelam Siddiqui; Aamer Aleem; Abdulrahman Al Diab
Journal:  Int Urol Nephrol       Date:  2007-06-05       Impact factor: 2.370

10.  The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experience.

Authors:  Anne-Laure Poitou-Verkinder; Arnaud Francois; Fanny Drieux; Stéphane Lepretre; Bruno Legallicier; Bruno Moulin; Michel Godin; Dominique Guerrot
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

View more
  8 in total

Review 1.  PET imaging in renal cancer.

Authors:  Liza Lindenberg; Esther Mena; Peter L Choyke; Kirsten Bouchelouche
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

2.  2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma.

Authors:  Yanyan Zhao; Caixia Wu; Wei Li; Xueqi Chen; Ziao Li; Xuhe Liao; Yonggang Cui; Guangyu Zhao; Meng Liu; Zhanli Fu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08-19       Impact factor: 9.236

3.  Genitourinary involvement of lymphomas on FDG-PET.

Authors:  Nikita Naik; Michael Lin; Peter Lin
Journal:  Br J Radiol       Date:  2018-05-03       Impact factor: 3.039

4.  Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma.

Authors:  Xuejin Ou; Jian Wang; Ruofan Zhou; Sha Zhu; Fuwen Pang; Yi Zhou; Rong Tian; Xuelei Ma
Journal:  Contrast Media Mol Imaging       Date:  2019-02-25       Impact factor: 3.161

5.  Concomitant occurrence of primary renal non-Hodgkin lymphoma and a colon cancer: A rare case report.

Authors:  Ji Li; Yabin Zou; Bin Wang; Xiangwei Meng; Xun Sun
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

6.  Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015).

Authors:  Alankrita Taneja; Vivek Kumar; Abhinav B Chandra
Journal:  Eur J Haematol       Date:  2020-03-03       Impact factor: 2.997

7.  Radiomics based on 18 F-FDG PET/CT could differentiate breast carcinoma from breast lymphoma using machine-learning approach: A preliminary study.

Authors:  Xuejin Ou; Jing Zhang; Jian Wang; Fuwen Pang; Yongsheng Wang; Xiawei Wei; Xuelei Ma
Journal:  Cancer Med       Date:  2019-11-25       Impact factor: 4.452

8.  Editorial Comment to A case of perirenal non-specific lymphadenitis mimicking a solitary renal mass.

Authors:  Masashi Kubota; Mutsushi Kawakita
Journal:  IJU Case Rep       Date:  2021-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.